Altimmune
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $5 | $5 | $5 | $5 |
Gross Profit | 5 | 5 | -56 | -102 |
EBITDA | -23,146 | -22,802 | -24,578 | -24,287 |
EBIT | -23,179 | -22,839 | -24,639 | -24,394 |
Net Income | -23,180 | -22,845 | -24,640 | -24,394 |
Net Change In Cash | 5 | 5 | 5 | 5 |
Free Cash Flow | -18,265 | -27,118 | -18,108 | -16,357 |
Cash | 36,926 | 31,474 | 57,128 | 79,019 |
Basic Shares | 71,260 | 71,084 | 70,924 | 70,801 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $20 | $426 | $-68 | $4,410 |
Gross Profit | 20 | -51 | -136 | 3,859 |
EBITDA | -94,812 | -87,935 | -84,402 | -96,533 |
EBIT | -95,050 | -88,412 | -84,902 | -97,085 |
Net Income | -95,059 | -88,447 | -84,713 | -96,171 |
Net Change In Cash | 20 | 426 | -68 | 4,410 |
Cost of Revenue | 74,382 | |||
Free Cash Flow | -79,848 | -75,857 | -62,712 | -90,549 |
Cash | 36,926 | 135,117 | 111,097 | 190,300 |
Basic Shares | 71,003 | 53,246 | 46,926 | 41,283 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.33 |
2024-09-30 | -$0.32 |
2024-06-30 | -$0.35 |
2024-03-31 | -$0.34 |
